Key points are not available for this paper at this time.
To facilitate the detection and management of potential clinical antiviral resistance, in vitro selection of drug-resistant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) against the virus M
Zhu et al. (2024) studied this question.